WO2017104759A1 - Tablet-type freeze-dried cosmetic - Google Patents

Tablet-type freeze-dried cosmetic Download PDF

Info

Publication number
WO2017104759A1
WO2017104759A1 PCT/JP2016/087423 JP2016087423W WO2017104759A1 WO 2017104759 A1 WO2017104759 A1 WO 2017104759A1 JP 2016087423 W JP2016087423 W JP 2016087423W WO 2017104759 A1 WO2017104759 A1 WO 2017104759A1
Authority
WO
WIPO (PCT)
Prior art keywords
tablet
mass
cosmetic
dried
type freeze
Prior art date
Application number
PCT/JP2016/087423
Other languages
French (fr)
Japanese (ja)
Inventor
雅之 菊田
Original Assignee
株式会社 資生堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社 資生堂 filed Critical 株式会社 資生堂
Publication of WO2017104759A1 publication Critical patent/WO2017104759A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to tablet-type freeze-dried cosmetics, and more particularly to the improvement of handling ease as a tablet.
  • Patent Document 1 discloses L-ascorbic acid-2-phosphate, which is unstable in the presence of water, sugar alcohol, oligosaccharide having low hygroscopicity, and a technique relating to dry formulation of a liquid composition. It is described that an aqueous solution mixed with a water-soluble polymer can be kept stable until use by lyophilization.
  • Patent Document 2 discloses that a freeze-dried cosmetic obtained by freeze-drying an aqueous solution containing sodium hyaluronate, collagen, and an ascorbic acid derivative shrinks or cracks due to moisture absorption, bacteria and oxidation even after long-term storage. It is described that it dissolves in a very short time when it is redissolved with water or lotion during use.
  • Patent Document 3 describes that a hyaluronic acid solid composition stable at room temperature was obtained by freeze-drying an aqueous solution containing sodium hyaluronate and a saccharide.
  • Patent Document 4 a powder or granular cosmetic using a freeze-dried product of an aqueous solution containing hyaluronic acid or sodium hyaluronate and phosphoric acid-L-ascorbyl magnesium exhibits the solubility of both components in water. It is described to improve.
  • the freeze-dried compositions taught in Patent Documents 1 to 4 are not sufficient in terms of peelability from a container or the like, re-solubility, and feeling of use of the re-dissolved liquid as a molded tablet-shaped freeze-dried product. It has been difficult to produce tablet-type cosmetics that are highly portable and can be used easily. In particular, a technique relating to a tablet that has a low hygroscopicity during storage but dissolves instantly when water is added is not yet known. This invention is made
  • the inventors of the present invention comprising a polyethylene glycol of specific molecular weight and trehalose, and a composition formed into a tablet shape by freeze-drying so as to have a specific bulk specific gravity
  • the present invention was completed by finding that it dissolves instantly by addition of water despite its low hygroscopicity, has high releasability, and is easy to handle.
  • the tablet-type freeze-dried cosmetic according to the present invention is (A) 10-20% by mass of trehalose, (B) 0.5 to 3.0% by mass of polyethylene glycol having a number average molecular weight of 2500 to 20000, And having a bulk specific gravity of 0.1 to 0.5 g / ml.
  • (B) preferably contains polyethylene glycol having a number average molecular weight of 15000 to 20000.
  • the cosmetic preferably comprises (C) hyaluronic acid and (D) a thickener. In the cosmetic, it is preferable that the blending amount of (C) hyaluronic acid is 0.01 to 1% by mass.
  • the blending amount of (D) thickener is 0.01 to 0.5% by mass.
  • the thickener is preferably selected from xanthan gum, tamarind gum, sodium alginate, gellan gum, agar, polyvinyl alcohol, carboxyvinyl polymer, and quince seed.
  • the tablet-type freeze-dried cosmetics applied to the skin etc. which can be melt
  • the tablet-type freeze-dried cosmetic according to the present invention contains trehalose and polyethylene glycol having a specific number average molecular weight, and is basically produced by volatilizing a medium from a uniform solution / dispersion solution of the components. It is. First, the components of the present invention will be described.
  • Ingredients blended as an excipient in the present invention are (A) trehalose and (B) polyethylene glycol.
  • Trehalose used in the present invention is a disaccharide in which two D-glucoses are linked, and the binding mode is ⁇ , ⁇ -, ⁇ , ⁇ -, ⁇ , ⁇ - There are three types, and ⁇ , ⁇ -binding modes that are found in large numbers in nature are common.
  • Trehalose a type of sugar, has strong water retention, and is superior in terms of stability, resolubility and releasability as a freeze-dried cosmetic compared to sugars such as erythritol, xylitol, and sorbitol. Yes.
  • the amount of trehalose is preferably 10 to 20% by mass. Further, the content of 15 to 20% by mass is more preferable from the viewpoint of excellent high temperature stability. If it is less than 10% by mass, it is not preferable in that the stability at high temperatures and the solubility in water during re-dissolution may be insufficient. On the other hand, if it exceeds 20% by mass, the high temperature resistance is excellent, it is difficult to freeze, there is a case where bumping may occur, and it is not preferable from the viewpoint of usability.
  • trehalose for cosmetics
  • Hayashibara Co., Ltd. examples of commercially available trehalose
  • trehalose In addition to trehalose, other saccharides can be added as long as the effects of the present invention are not lost.
  • maltose, maltotetraose, maltosyl trehalose and the like can be mentioned.
  • Polyethylene glycol used in the present invention includes those having a number average molecular weight of 2500 to 20000 from the viewpoint of tablet formability. More preferably, it is preferably 15000 to 20000 in terms of moldability and releasability. When the number average molecular weight is less than 2500, it is not preferable in that the releasability may be deteriorated. Moreover, when the number average molecular weight is larger than 20000, it is not preferable in that re-solubility is poor and feeling in use may be inferior.
  • the blending amount of (B) polyethylene glycol is preferably 0.5 to 5% by mass, more preferably 0.5 to 3%, and further preferably 1 to 2% by mass with respect to the pre-lyophilization solution of the present invention. is there. When it mixes exceeding 5 mass%, the mold release property and usability of a tablet may fall.
  • the said polyethylene glycol may use what was synthesize
  • commercially available polyethylene glycol include PEG-20000 (manufactured by Sanyo Chemical Industries, Ltd.).
  • Hyaluronic acid used in the present invention is a linear polymer in which N-acetyl-D-glucosamine residues and D-glucuronic acid residues are alternately bonded. What was processed into the powder form etc. can be used.
  • the hyaluronic acid can be obtained by, for example, isolation and extraction from a chicken crown or other animal tissues, or a fermentation method using a microorganism such as Streptococcus.
  • a hyaluronic acid metal salt such as hyaluronic acid sodium salt and hyaluronic acid potassium salt
  • a hydroxyl group and a carboxyl group of hyaluronic acid are etherified, esterified and amidated.
  • powders such as hyaluronic acid derivatives obtained by acetylation, acetalization, and ketalization may be used.
  • hyaluronic acid examples include hyaluronic acid HA-LQ (manufactured by Kewpie Fine Chemical), hyaluronic acid FCH (manufactured by Kikkoman Biochemifa Co., Ltd.), and the like.
  • the molecular weight of (C) hyaluronic acid is not particularly limited, but it is preferable that the molecular weight is 100,000 or more, and the molecular weight is about 500,000 to 3,000,000.
  • the molecular weight is 100,000 or more, and the molecular weight is about 500,000 to 3,000,000.
  • the molecular weight is larger than 3 million, it is not preferable in that the solubility and the feeling of use after re-dissolution may be insufficient.
  • (C) hyaluronic acid in particular, exhibits extremely high viscosity even in the state of a low concentration aqueous solution, so its blending amount is related to the properties of the lyophilized tablet and its redissolved solution. Is expensive.
  • the blending amount of (C) hyaluronic acid is preferably 0.01 to 1% by mass, more preferably 0.05 to 0.2% by mass with respect to the pre-lyophilized solution of the present invention. If it exceeds 1% by mass, the solubility and releasability of the tablet will decrease, which is not preferable.
  • the (D) thickener used for this invention is used in order to improve the moldability and mold release property of tablet cosmetics.
  • a thickener water-soluble polymers such as xanthan gum, tamarind gum, sodium alginate, gellan gum, agar, polyvinyl alcohol, carboxyvinyl polymer, and quince seed can be used. Among these, it is preferable to use xanthan gum, tamarind gum, and quince seed in terms of using a tablet cosmetic and having less stickiness when dry, and less stickiness.
  • the blending amount of the thickener is preferably 0.01 to 0.5% by mass, more preferably 0.05 to 0.1% by mass, based on the pre-lyophilized solution of the present invention. If it exceeds 0.5% by mass, the releasability and usability of the tablet may decrease, and if the amount is less than 0.01% by mass, the moldability and releasability may decrease. is there.
  • thickeners examples include xanthan gum (Celtrol, manufactured by Kelco), tamarind gum (Glyloid 6C, manufactured by Dainippon Pharmaceutical Co., Ltd.), sodium alginate (Duck Algin NSPH, Kikkoman Biochemifa Corporation). ), Gellan gum (Kelcogel, DSP Gokyo Food & Chemical Co., Ltd.), agar (Inagar CS-110, Ina Food Industry Co., Ltd.), and the like.
  • the tablet-type freeze-dried cosmetic composition according to the present invention may contain other components that can be added to normal cosmetics and quasi-drugs as long as the effects of the present invention are not impaired.
  • an aqueous component is particularly preferable as the other component, but an oily component can be blended by solubilization using a surfactant or the like.
  • the aqueous component include polyhydric alcohols, water-soluble polymers other than the component (D), chelating agents, pH adjusters, preservatives, and the like.
  • polyhydric alcohol examples include ethylene glycol, propylene glycol, 1,3-butylene glycol, glycerol, polyethylene glycol having a molecular weight other than those described above, polyglycerol, and the like.
  • water-soluble polymers include those other than those described above, for example, hydrophilic synthetic polymers such as polyacrylic acid, polyethylene glycol, polyacrylamide, polyalkylacrylamide / polyacrylamide copolymer, carboxymethylcellulose, cationized cellulose, pluronic, macrogol.
  • hydrophilic synthetic polymers such as polyacrylic acid, polyethylene glycol, polyacrylamide, polyalkylacrylamide / polyacrylamide copolymer, carboxymethylcellulose, cationized cellulose, pluronic, macrogol.
  • hydrophilic natural polymers such as succinoglycan, guar gum, locust bean gum, curdlan, alginic acid, carrageenan, mannan, pectin, gum arabic, karaya gum, casein, ⁇ -cyclodextrin, Dextrin, dextran, gelatin, collagen, pectin, starch, chitin and its derivatives, chitosan and its derivatives, elastin, heparin, heparan Acid, methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose; as a hydrophilic clay mineral, laponite, bentonite, smectite, and the like.
  • Examples of the chelating agent include 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, disodium edetate, trisodium edetate, tetrasodium edetate, Examples include sodium acid, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, edetic acid, and trisodium ethylenediaminehydroxyethyl triacetate.
  • pH adjuster examples include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
  • preservative examples include paraoxybenzoic acid ester and phenoxyethanol.
  • oil component examples include fragrances and oil-based drugs (for example, vitamin A).
  • humectants eg, 2-methacryloyloxyethyl phosphorylcholine (MPC) copolymer, PEG / PPG dimethyl ether such as PEG / PPG-14 / 7 dimethyl ether
  • water-soluble collagen e.g, hydrogen peroxide treatment Yeast hydrolysate, sodium dl-prolidonecarboxylate, L-hydroxyproline, calcium chloride, magnesium chloride
  • various extracts eg, rose, apricot, auren, sicon, peonies, assembly, birch, sage, loquat, carrot , Aloe, mallow, iris, grape, yokuinin, loofah, lily, saffron, senkyo, ginger, hypericum, onionis, garlic, capsicum, chimpi, cypress, seaweed, etc.
  • other water-soluble drugs eg, tranexamic acid
  • the tablet-type cosmetics according to the present invention can be obtained as a dry product that remains after dissolving or dispersing the above-described blended components in a volatile liquid medium such as water or lower alcohol, and sublimating by freezing after freezing.
  • a volatile liquid medium such as water or lower alcohol
  • the excipient component dissolved in a medium forms a three-dimensional network structure in the medium. If only the medium is removed from such a state, the network structure shrinks due to drying, and is distorted or collapsed. Therefore, it is usually difficult to maintain the structure.
  • trehalose blended with the excipient supports the network structure instead of the medium even after volatilization of the medium, so that it is considered that the structure by the excipient is almost maintained.
  • the dried product in which the three-dimensional network structure of the excipient is maintained is in a porous state in which the medium portion has been removed from the structure.
  • water is added during re-dissolution, water is introduced into the network structure from each hole. Penetration and dissolution of the entire tablet formulation proceeds. At that time, the higher the density of the constituents including the structure, the more difficult the water penetrates into the interior, and the formulation becomes less soluble. On the other hand, if the density of the constituent components is too low, the preparation itself is fragile and easily collapses, and it is easy to absorb moisture during storage.
  • the bulk density of the constituents is further set within a certain range.
  • the tablet cosmetic according to the present invention contains the above-described constituents and has a bulk specific gravity of 0.1 to 0.5 g / ml, preferably 0.15 to 0.3 g / ml. Cost. If the bulk specific gravity is less than 0.1 g / ml, the hygroscopicity during storage increases, and if it exceeds 0.5 g / ml, the solubility in water tends to decrease. On the other hand, if the bulk specific gravity is within the above range, the number of holes through which the medium has escaped is moderately large, and the network structure of the thickener is also fixed in a moderately widened state. In this case, the solubility is extremely good.
  • the tablet weight after freeze-drying (g) ⁇ freeze-drying type volume (ml) is calculated.
  • the tablet-type cosmetic according to the present invention is, for example, filled in a tablet mold with a solution in which constituent components are dissolved or dispersed in a volatile liquid medium such as water or lower alcohol, and then freeze-dried. It can manufacture by taking out from.
  • the present invention can be molded into any size and shape by setting the volume of the preparation, the components and the amount of the medium so as to satisfy the above-mentioned bulk specific gravity.
  • an extremely thin shape or an excessively complicated shape is not preferable because there is a problem in moldability.
  • the present invention has a low hygroscopic property of the preparation, and has a high releasability and is easily peeled from the container. Therefore, the present invention is not limited to a form (for example, blister pack) packaged for each used portion while being filled in the container. Only the preparation removed from the mold) can be packaged in any form.
  • the tablet-type cosmetics according to the present invention can usually be used by adding an appropriate amount of water to redissolve the preparation and applying the solution to the skin or the like.
  • the amount of water to be added should be adjusted so that the viscosity is easy to apply, with the lower limit of the complete dissolution of the preparation, but if it is too much, the component concentration is too low to obtain a sufficient effect. Yes, if it is too little, it may become sticky at the time of application. Therefore, although not particularly limited, it is preferable to adjust the addition amount to about 1 to 10 times the volume of the preparation.
  • the place where water is added to the preparation may be on the palm, on the application site, or in a suitable container.
  • the preparation for one-time use is placed on the palm. After adding water, it is preferable to apply the solution on the palm as it is to the application site by hand. Note that lotion or the like may be used instead of water as long as the formulation can be redissolved.
  • the tablet-type cosmetic according to the present invention may be in any product form, such as lotion, cosmetic liquid, pack, cleansing, facial cleansing foam, hand cream, shampoo, rinse, hair treatment, sunscreen, etc., depending on the ingredients to be blended.
  • it is suitable for use as a moisturizing lotion or cosmetic liquid.
  • ⁇ Moldability> The moldability after the drying step in the production method of each test example composition was evaluated according to the following criteria.
  • test example compositions of the formulations described in the following tables were prepared according to the following production methods.
  • a volatile liquid medium such as water or lower alcohol
  • poured into a mold sublimed by freezing after freezing, and a tablet-type freeze-dried cosmetic was obtained as a dry product remaining later.
  • the present inventor further examined the usability as a tablet cosmetic.
  • the polyethylene glycol (B) preferably has a number average molecular weight of 4,000 to 20,000 in terms of moldability and usability.
  • Test Examples 7-1 to 7-6 were tablet cosmetics excellent in re-dissolvability and usability, and excellent in high-temperature stability.
  • the formulation example of the tablet-type freeze-dried cosmetic (detergent) of the present invention is as follows.
  • the formulation example of the tablet-type freeze-dried cosmetic (hair treatment) of the present invention is as follows.
  • the formulation example of the tablet-type freeze-dried cosmetic (shampoo) of the present invention is as follows.
  • Formulation examples 4 to 7 of the tablet-type freeze-dried cosmetic (cosmetic for skin application) of the present invention are as follows.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

A tablet-type cosmetic excellent in handleability is provided. The tablet-type cosmetic according to the present invention contains (A) 10-20% by mass of trehalose and (B) 0.5-3.0% by mass of polyethylene glycol having a molecular weight of 2,500-20,000, and has a bulk specific gravity of 0.1-0.5 g/ml.

Description

タブレット型凍結乾燥化粧料Tablet-type freeze-dried cosmetics 関連出願Related applications
 本出願は、2015年12月16日付け出願の日本国特許出願2015-245470号の優先権を主張しており、ここに折り込まれるものである。 This application claims the priority of Japanese Patent Application No. 2015-245470 filed on December 16, 2015, and is incorporated herein.
 本発明はタブレット型凍結乾燥化粧料、特にそのタブレットとしての取り扱い易さの向上に関する。 The present invention relates to tablet-type freeze-dried cosmetics, and more particularly to the improvement of handling ease as a tablet.
 通常、有効成分が配合された高機能のスキンケア化粧品は、主に化粧水や美容液等の液体の状態で供され、毎日習慣的に用いることによって、その効果が発揮される。
 一方で、近年では、旅先や出張先、あるいはスポーツジム等においてスキンケアが行われる機会が増加していることから、携帯の際に負担の少ない製品が求められている。さらに、近年の美容意識の向上から、出先で使用するスキンケア化粧品について、日常のケアと同等以上の満足感の得られる質の高い製品が要求されている。
 また、上記のような携帯用に限らず、日常的に、あるいは肌の状態に応じて使用するスキンケア化粧品においても、手軽にかつカスタマイズして使用できる形態の製品の要求は高い。
Usually, highly functional skin care cosmetics containing active ingredients are provided mainly in the form of liquids such as skin lotions and cosmetic liquids, and their effects are exhibited by daily habitual use.
On the other hand, in recent years, there are increasing opportunities for skin care to be performed at travel destinations, business trip destinations, sports gyms, and the like, and therefore, products that have less burden when being carried are required. Furthermore, with the recent improvement in beauty consciousness, there is a demand for high-quality products that can achieve a level of satisfaction equivalent to or better than daily care for skin care cosmetics used on the go.
In addition, not only for portable use as described above, but also for skin care cosmetics that are used on a daily basis or according to the skin condition, there is a high demand for products that can be used easily and customized.
 上記のような要求に応じる手段の一つとして、化粧水等液状の組成物を乾燥製剤とし、これを使用時に水に再溶解して使用するような形態が考えられる。
 液状組成物の乾燥製剤化に関する技術として、例えば、特許文献1には、水との共存下で不安定なL-アスコルビン酸-2-リン酸塩を、糖アルコールと低吸湿性のオリゴ糖及び水溶性高分子と混合した水溶液とし、凍結乾燥を行うことにより、使用時まで安定に保てることが記載されている。
 また、特許文献2には、ヒアルロン酸ナトリウム、コラーゲンおよびアスコルビン酸誘導体を配合した水溶液を凍結乾燥させることにより得られた凍結乾燥化粧品が、長期間保存後でも吸湿による収縮や割れ、細菌類や酸化による変質等がなく、かつ使用時に水または化粧水で再溶解する際に極めて短時間で溶解することが記載されている。
 また、特許文献3には、ヒアルロン酸ナトリウムと糖類を含む水性溶液を凍結乾燥することにより、室温に安定なヒアルロン酸固形組成物を得たことが記載されている。
 また、特許文献4においても、ヒアルロン酸あるいはヒアルロン酸ナトリウムとリン酸-L-アスコルビルマグネシウムを含有する水溶液の凍結乾燥品を用いた粉末あるいは顆粒状化粧料が、両成分の水への溶解性を改善することが記載されている。
As one of means for satisfying the above requirements, a form in which a liquid composition such as a skin lotion is used as a dry preparation, which is redissolved in water at the time of use can be considered.
For example, Patent Document 1 discloses L-ascorbic acid-2-phosphate, which is unstable in the presence of water, sugar alcohol, oligosaccharide having low hygroscopicity, and a technique relating to dry formulation of a liquid composition. It is described that an aqueous solution mixed with a water-soluble polymer can be kept stable until use by lyophilization.
Patent Document 2 discloses that a freeze-dried cosmetic obtained by freeze-drying an aqueous solution containing sodium hyaluronate, collagen, and an ascorbic acid derivative shrinks or cracks due to moisture absorption, bacteria and oxidation even after long-term storage. It is described that it dissolves in a very short time when it is redissolved with water or lotion during use.
Patent Document 3 describes that a hyaluronic acid solid composition stable at room temperature was obtained by freeze-drying an aqueous solution containing sodium hyaluronate and a saccharide.
Also in Patent Document 4, a powder or granular cosmetic using a freeze-dried product of an aqueous solution containing hyaluronic acid or sodium hyaluronate and phosphoric acid-L-ascorbyl magnesium exhibits the solubility of both components in water. It is described to improve.
特開2004-149468号公報JP 2004-149468 A 特開2006-182750号公報JP 2006-182750 A 特開2003-95955号公報JP 2003-95955 A 特開平2-215707号公報JP-A-2-215707
 しかしながら、特許文献1~4に教示される凍結乾燥組成物は、成形したタブレット型の凍結乾燥物として容器等からの剥離性や再溶解性、再溶解液の使用感といった点で十分ではなく、携帯性が高く、手軽に使用可能なタブレット型化粧料として製造することは難しかった。特に、保存時の吸湿性が低い一方で、水を添加すると瞬時に溶解するような溶解性をもつタブレットに関する技術は未だ知られていない。
 本発明は、上記事情を鑑みなされたものであり、取り扱い易さに優れたタブレット型凍結乾燥化粧料を提供することを目的としている。
However, the freeze-dried compositions taught in Patent Documents 1 to 4 are not sufficient in terms of peelability from a container or the like, re-solubility, and feeling of use of the re-dissolved liquid as a molded tablet-shaped freeze-dried product. It has been difficult to produce tablet-type cosmetics that are highly portable and can be used easily. In particular, a technique relating to a tablet that has a low hygroscopicity during storage but dissolves instantly when water is added is not yet known.
This invention is made | formed in view of the said situation, and it aims at providing the tablet type freeze-drying cosmetics excellent in the ease of handling.
 本発明者らは、上記課題を解決するために鋭意検討した結果、特定分子量のポリエチレングリコールとトレハロースとを含み、且つ特定の嵩比重となるように凍結乾燥によりタブレット型に形成した組成物が、吸湿性が低いにもかかわらず水の添加により瞬時に溶解し、離型性が高く、取り扱い易さに優れたものであることを見出し、本発明を完成するにいたった。
 すなわち、本発明に係るタブレット型凍結乾燥化粧料は、
 (A)トレハロースを10~20質量%と、
 (B)数平均分子量が2500~20000のポリエチレングリコールを0.5~3.0質量%と、
を含み、且つ、嵩比重が0.1~0.5g/mlであることを特徴とする。
 前記化粧料において、(B)は数平均分子量15000~20000のポリエチレングリコールを含むことが好適である。
 前記化粧料において、(C)ヒアルロン酸及び(D)増粘剤を含むことが好適である。
 前記化粧料において、(C)ヒアルロン酸の配合量が0.01~1質量%であることが好適である。
  前記化粧料において、(D)増粘剤の配合量が0.01~0.5質量%であることが好適である。
 前記化粧料において、(D)増粘剤がキサンタンガム、タマリンドガム、アルギン酸ナトリウム、ジェランガム、寒天、ポリビニルアルコール、カルボキシビニルポリマー、クインスシードから選択されることが好適である。
As a result of intensive studies to solve the above-mentioned problems, the inventors of the present invention, comprising a polyethylene glycol of specific molecular weight and trehalose, and a composition formed into a tablet shape by freeze-drying so as to have a specific bulk specific gravity, The present invention was completed by finding that it dissolves instantly by addition of water despite its low hygroscopicity, has high releasability, and is easy to handle.
That is, the tablet-type freeze-dried cosmetic according to the present invention is
(A) 10-20% by mass of trehalose,
(B) 0.5 to 3.0% by mass of polyethylene glycol having a number average molecular weight of 2500 to 20000,
And having a bulk specific gravity of 0.1 to 0.5 g / ml.
In the cosmetic, (B) preferably contains polyethylene glycol having a number average molecular weight of 15000 to 20000.
The cosmetic preferably comprises (C) hyaluronic acid and (D) a thickener.
In the cosmetic, it is preferable that the blending amount of (C) hyaluronic acid is 0.01 to 1% by mass.
In the cosmetic, it is preferable that the blending amount of (D) thickener is 0.01 to 0.5% by mass.
In the cosmetic, (D) the thickener is preferably selected from xanthan gum, tamarind gum, sodium alginate, gellan gum, agar, polyvinyl alcohol, carboxyvinyl polymer, and quince seed.
 本発明によれば、トレハロースおよび特定の数平均分子量のポリエチレングリコールの配合により、少量の水を加えることにより瞬時に溶解できる皮膚等に適用されるタブレット型凍結乾燥化粧料が得られる。また、前記タブレット型化粧料は吸湿が極めて少なく、携帯性や手軽さを備えた化粧料の提供を可能とする。
 また、さらに、ヒアルロン酸及び増粘剤を配合した場合には、使用性に優れたタブレット型凍結乾燥化粧料を得られる。
ADVANTAGE OF THE INVENTION According to this invention, the tablet-type freeze-dried cosmetics applied to the skin etc. which can be melt | dissolved instantly by adding a small amount of water by the combination of a trehalose and the polyethylene glycol of a specific number average molecular weight are obtained. Further, the tablet-type cosmetics have very little moisture absorption, and can provide cosmetics with portability and ease.
Furthermore, when hyaluronic acid and a thickener are blended, a tablet-type freeze-dried cosmetic with excellent usability can be obtained.
 以下、本発明について詳細に説明する。
 本発明に係るタブレット型凍結乾燥化粧料は、トレハロースと、特定の数平均分子量のポリエチレングリコールとを含み、基本的に、該成分の均一溶解・分散液から媒体を揮発させることによって製造されるものである。まず、本発明の構成成分について説明する。
Hereinafter, the present invention will be described in detail.
The tablet-type freeze-dried cosmetic according to the present invention contains trehalose and polyethylene glycol having a specific number average molecular weight, and is basically produced by volatilizing a medium from a uniform solution / dispersion solution of the components. It is. First, the components of the present invention will be described.
<賦形剤>
 本発明に賦形剤として配合される成分は、(A)トレハロース、(B)ポリエチレングリコールである。
<Excipient>
Ingredients blended as an excipient in the present invention are (A) trehalose and (B) polyethylene glycol.
 (A)トレハロース
 本発明に使用される(A)トレハロースは、D-グルコースが2つ結合した形の2糖類であり、その結合様式はα,α-、α,β-、β,β-の3種類があり、天然に多く存在が認められるα,α-の結合様式のものが一般的である。
(A) Trehalose (A) Trehalose used in the present invention is a disaccharide in which two D-glucoses are linked, and the binding mode is α, α-, α, β-, β, β- There are three types, and α, α-binding modes that are found in large numbers in nature are common.
 糖の一種であるトレハロースは、強い保水力を持っているため、エリスリトール、キシリトール、ソルビトールなどの糖に比べて、凍結乾燥化粧料としての安定性、再溶解性および離型性の点で優れている。 Trehalose, a type of sugar, has strong water retention, and is superior in terms of stability, resolubility and releasability as a freeze-dried cosmetic compared to sugars such as erythritol, xylitol, and sorbitol. Yes.
 トレハロースの配合量は、10~20質量%であると好ましい。また、15~20質量%であると、高温安定性に優れる点でより好ましい。10質量%未満であると、高温安定性および再溶解時の水への溶解性が十分でない場合がある点で好ましくない。また、20質量%を超えると、高温耐性は優れているもの、凍結しにくく突沸するような場合がある点や使用感の点で好ましくない。 The amount of trehalose is preferably 10 to 20% by mass. Further, the content of 15 to 20% by mass is more preferable from the viewpoint of excellent high temperature stability. If it is less than 10% by mass, it is not preferable in that the stability at high temperatures and the solubility in water during re-dissolution may be insufficient. On the other hand, if it exceeds 20% by mass, the high temperature resistance is excellent, it is difficult to freeze, there is a case where bumping may occur, and it is not preferable from the viewpoint of usability.
 トレハロースの市販品としては、例えば、トレハロース(化粧品用)(株式会社林原社製)等が挙げられる。 Examples of commercially available trehalose include trehalose (for cosmetics) (manufactured by Hayashibara Co., Ltd.).
 トレハロースの他に本発明の効果を失わない範囲で、その他の糖類を加えることができる。
 たとえば、マルトース、マルトテトラオース、マルトシルトレハロースなどが挙げられる。
In addition to trehalose, other saccharides can be added as long as the effects of the present invention are not lost.
For example, maltose, maltotetraose, maltosyl trehalose and the like can be mentioned.
 (B)ポリエチレングリコール
 本発明に使用される(B)ポリエチレングリコールとしては、タブレットの賦形性の点から、数平均分子量が2500~20000のものが挙げられる。より好ましくは、15000~20000であると、成型性や離型性の点で好ましい。
 数平均分子量が、2500未満であると、離型性が悪くなるという場合がある点で好ましくない。また、数平均分子量が、20000より大きいと、再溶解性が悪い、使用感が劣るという場合がある点で好ましくない。
(B) Polyethylene glycol (B) Polyethylene glycol used in the present invention includes those having a number average molecular weight of 2500 to 20000 from the viewpoint of tablet formability. More preferably, it is preferably 15000 to 20000 in terms of moldability and releasability.
When the number average molecular weight is less than 2500, it is not preferable in that the releasability may be deteriorated. Moreover, when the number average molecular weight is larger than 20000, it is not preferable in that re-solubility is poor and feeling in use may be inferior.
 (B)ポリエチレングリコールの配合量は、本発明の凍結乾燥前溶液に対し、好ましくは0.5~5質量%、よりに好ましくは0.5~3%、さらに好ましくは1~2質量%である。5質量%を超えて配合すると、タブレットの離型性や使用感が低下することがある。 The blending amount of (B) polyethylene glycol is preferably 0.5 to 5% by mass, more preferably 0.5 to 3%, and further preferably 1 to 2% by mass with respect to the pre-lyophilization solution of the present invention. is there. When it mixes exceeding 5 mass%, the mold release property and usability of a tablet may fall.
 また、前記ポリエチレングリコールは、公知の合成方法により合成したものを用いても、市販品を用いてもよい。
 ポリエチレングリコールの市販品としては、例えば、PEG-20000(三洋化成工業株式会社製)等が挙げられる。
Moreover, the said polyethylene glycol may use what was synthesize | combined by the well-known synthesis | combining method, or may use a commercial item.
Examples of commercially available polyethylene glycol include PEG-20000 (manufactured by Sanyo Chemical Industries, Ltd.).
 (C)ヒアルロン酸
 本発明に使用される(C)ヒアルロン酸は、N-アセチル-D-グルコサミン残基と、D-グルクロン酸残基が交互に結合した直鎖状高分子であり、これを粉末状に加工したもの等を用いることができる。
(C) Hyaluronic acid (C) Hyaluronic acid used in the present invention is a linear polymer in which N-acetyl-D-glucosamine residues and D-glucuronic acid residues are alternately bonded. What was processed into the powder form etc. can be used.
 前記ヒアルロン酸は、例えば、鶏冠や他の動物組織からの単離抽出、あるいはストレプト・コッカス属などの微生物を用いた発酵法により得ることができる。また、本発明においては、例えば、ヒアルロン酸の誘導体として、ヒアルロン酸ナトリウム塩、ヒアルロン酸カリウム塩等のヒアルロン酸金属塩や、ヒアルロン酸のヒドロキシル基、カルボキシル基等をエーテル化、エステル化、アミド化、アセチル化、アセタール化、ケタール化させて得られるヒアルロン酸誘導体等の粉末を用いても構わない。
 また、ヒアルロン酸として市販品を用いることもできる。市販のヒアルロン酸としては、例えば、ヒアルロン酸HA-LQ(キューピーファインケミカル社製)、ヒアルロン酸FCH(キッコーマンバイオケミファ株式会社製)等が挙げられる。
The hyaluronic acid can be obtained by, for example, isolation and extraction from a chicken crown or other animal tissues, or a fermentation method using a microorganism such as Streptococcus. Further, in the present invention, for example, as a derivative of hyaluronic acid, a hyaluronic acid metal salt such as hyaluronic acid sodium salt and hyaluronic acid potassium salt, and a hydroxyl group and a carboxyl group of hyaluronic acid are etherified, esterified and amidated. Alternatively, powders such as hyaluronic acid derivatives obtained by acetylation, acetalization, and ketalization may be used.
Moreover, a commercial item can also be used as hyaluronic acid. Examples of commercially available hyaluronic acid include hyaluronic acid HA-LQ (manufactured by Kewpie Fine Chemical), hyaluronic acid FCH (manufactured by Kikkoman Biochemifa Co., Ltd.), and the like.
 また、(C)ヒアルロン酸の分子量は、特に限定されるものではないが、分子量10万以上、さらには分子量が50万~300万程度であることが好適である。10万未満に低分子化されたヒアルロン酸を用いると、タブレットへの賦形性や再溶解後の使用感が十分でないことがある。また、分子量が、300万より大きいと、溶解性や再溶解後の使用感が十分でないという場合がある点で好ましくない。 The molecular weight of (C) hyaluronic acid is not particularly limited, but it is preferable that the molecular weight is 100,000 or more, and the molecular weight is about 500,000 to 3,000,000. When hyaluronic acid having a low molecular weight of less than 100,000 is used, the formability to tablets and the feeling of use after re-dissolution may not be sufficient. On the other hand, if the molecular weight is larger than 3 million, it is not preferable in that the solubility and the feeling of use after re-dissolution may be insufficient.
 上記賦形剤のうち、特に(C)ヒアルロン酸は、低濃度の水溶液の状態でも極めて高い粘性を示すことから、その配合量は凍結乾燥後のタブレット及びその再溶解液の性質への関連性が高い。
 (C)ヒアルロン酸の配合量は、本発明の凍結乾燥前溶液に対し、好ましくは、0.01~1質量%、より好ましくは0.05~0.2質量%である。1質量%を超えて配合すると、タブレットの溶解性や離型性が低下してしまうため、好ましくない。
Among the above excipients, (C) hyaluronic acid, in particular, exhibits extremely high viscosity even in the state of a low concentration aqueous solution, so its blending amount is related to the properties of the lyophilized tablet and its redissolved solution. Is expensive.
The blending amount of (C) hyaluronic acid is preferably 0.01 to 1% by mass, more preferably 0.05 to 0.2% by mass with respect to the pre-lyophilized solution of the present invention. If it exceeds 1% by mass, the solubility and releasability of the tablet will decrease, which is not preferable.
 (D)増粘剤
 本発明に使用される(D)増粘剤は、タブレット化粧料の成型性や離型性を高めるために用いられる。
 (D)増粘剤としては、キサンタンガム、タマリンドガム、アルギン酸ナトリウム、ジェランガム、寒天、ポリビニルアルコール、カルボキシビニルポリマー、クインスシードなどの水溶性高分子を用いることができる。この中でも、タブレット化粧料を使用し、乾いた際のべたつきや、つっぱり感が少ないという点で、キサンタンガム、タマリンドガム、クインスシードを用いることが好ましい。
(D) Thickener The (D) thickener used for this invention is used in order to improve the moldability and mold release property of tablet cosmetics.
(D) As a thickener, water-soluble polymers such as xanthan gum, tamarind gum, sodium alginate, gellan gum, agar, polyvinyl alcohol, carboxyvinyl polymer, and quince seed can be used. Among these, it is preferable to use xanthan gum, tamarind gum, and quince seed in terms of using a tablet cosmetic and having less stickiness when dry, and less stickiness.
 (D)増粘剤の配合量は、本発明の凍結乾燥前溶液に対し、好ましくは0.01~0.5質量%、より好ましくは0.05~0.1質量%である。0.5質量%を超えて配合すると、タブレットの離型性や使用感が低下することがあり、配合量が0.01質量%未満であると、成型性や離型性が低下することがある。 (D) The blending amount of the thickener is preferably 0.01 to 0.5% by mass, more preferably 0.05 to 0.1% by mass, based on the pre-lyophilized solution of the present invention. If it exceeds 0.5% by mass, the releasability and usability of the tablet may decrease, and if the amount is less than 0.01% by mass, the moldability and releasability may decrease. is there.
 このような増粘剤の市販品としては、例えば、キサンタンガム(ケルトロール、ケルコ社製)、タマリンドガム(グリロイド6C、大日本製薬株式会社製)、アルギン酸ナトリウム(ダックアルギンNSPH、キッコーマンバイオケミファ株式会社製)、ジェランガム(ケルコゲル、DSP五協フード&ケミカル株式会社製)、寒天(伊那寒天CS-110、伊那食品工業株式会社製)などが挙げられる。 Examples of such commercially available thickeners include xanthan gum (Celtrol, manufactured by Kelco), tamarind gum (Glyloid 6C, manufactured by Dainippon Pharmaceutical Co., Ltd.), sodium alginate (Duck Algin NSPH, Kikkoman Biochemifa Corporation). ), Gellan gum (Kelcogel, DSP Gokyo Food & Chemical Co., Ltd.), agar (Inagar CS-110, Ina Food Industry Co., Ltd.), and the like.
 また、本発明に係るタブレット型凍結乾燥化粧料には、上記成分に加え、通常化粧品や医薬部外品に配合可能なその他の成分を、本発明の効果を損なわない範囲において含んでいてもよい。
 本発明の製造上、その他の成分としては、特に水性成分の使用が好ましいが、界面活性剤等を用いて可溶化するなどして、油性成分を配合することもできる。
 水性成分としては、例えば、多価アルコール、(D)成分以外の水溶性高分子、キレート剤、pH調整剤、防腐剤等が挙げられる。
In addition to the above components, the tablet-type freeze-dried cosmetic composition according to the present invention may contain other components that can be added to normal cosmetics and quasi-drugs as long as the effects of the present invention are not impaired. .
In the production of the present invention, the use of an aqueous component is particularly preferable as the other component, but an oily component can be blended by solubilization using a surfactant or the like.
Examples of the aqueous component include polyhydric alcohols, water-soluble polymers other than the component (D), chelating agents, pH adjusters, preservatives, and the like.
 多価アルコールとしては、例えば、エチレングリコール、プロピレングリコール、1,3-ブチレングリコール、グリセリン、上記以外の分子量のポリエチレングリコール、ポリグリセリン等が挙げられる。 Examples of the polyhydric alcohol include ethylene glycol, propylene glycol, 1,3-butylene glycol, glycerol, polyethylene glycol having a molecular weight other than those described above, polyglycerol, and the like.
 水溶性高分子としては、上記以外のもの、例えば、親水性合成高分子として、ポリアクリル酸、ポリエチレングリコール、ポリアクリルアミド、ポリアルキルアクリルアミド/ポリアクリルアミドコポリマー、カルボキシメチルセルロース、カチオン化セルロース、プルロニック、マクロゴール、ポピドン、ポリビニルメタクリレート、ポリエチレンイミン等;親水性天然高分子として、サクシノグリカン、グアーガム、ローカストビーンガム、カードラン、アルギン酸、カラギーナン、マンナン、ペクチン、アラビアゴム、カラヤガム、カゼイン、α-シクロデキストリン、デキストリン、デキストラン、ゼラチン、コラーゲン、ペクチン、デンプン、キチン及びその誘導体、キトサン及びその誘導体、エラスチン、ヘパリン、ヘパラン硫酸、メチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース等;親水性粘土鉱物として、ラポナイト、ベントナイト、スメクタイト等が挙げられる。 Examples of water-soluble polymers include those other than those described above, for example, hydrophilic synthetic polymers such as polyacrylic acid, polyethylene glycol, polyacrylamide, polyalkylacrylamide / polyacrylamide copolymer, carboxymethylcellulose, cationized cellulose, pluronic, macrogol. , Popidone, polyvinyl methacrylate, polyethyleneimine and the like; hydrophilic natural polymers such as succinoglycan, guar gum, locust bean gum, curdlan, alginic acid, carrageenan, mannan, pectin, gum arabic, karaya gum, casein, α-cyclodextrin, Dextrin, dextran, gelatin, collagen, pectin, starch, chitin and its derivatives, chitosan and its derivatives, elastin, heparin, heparan Acid, methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethyl cellulose; as a hydrophilic clay mineral, laponite, bentonite, smectite, and the like.
 キレート剤としては、例えば、1-ヒドロキシエタン-1,1-ジフォスホン酸、1-ヒドロキシエタン-1,1-ジフォスホン酸四ナトリウム塩、エデト酸二ナトリウム、エデト酸三ナトリウム、エデト酸四ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸、リン酸、クエン酸、アスコルビン酸、コハク酸、エデト酸、エチレンジアミンヒドロキシエチル三酢酸3ナトリウム等が挙げられる。 Examples of the chelating agent include 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, disodium edetate, trisodium edetate, tetrasodium edetate, Examples include sodium acid, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, edetic acid, and trisodium ethylenediaminehydroxyethyl triacetate.
 pH調整剤としては、例えば、乳酸-乳酸ナトリウム、クエン酸-クエン酸ナトリウム、コハク酸-コハク酸ナトリウム等の緩衝剤等が挙げられる。 Examples of the pH adjuster include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
 防腐剤としては、パラオキシ安息香酸エステル、フェノキシエタノール等が挙げられる。 Examples of the preservative include paraoxybenzoic acid ester and phenoxyethanol.
 また、油性成分としては、例えば、香料、油性薬剤(例えば、ビタミンA等)が挙げられる。 In addition, examples of the oil component include fragrances and oil-based drugs (for example, vitamin A).
 その他、配合可能成分としては、例えば、保湿剤(例えば、2-メタクロイルオキシエチルホスホリルコリン(MPC)コポリマー、PEG/PPG-14/7ジメチルエーテル等のPEG/PPGジメチルエーテル、水溶性コラーゲン、過酸化水素処理酵母加水分解物、dl-プロリドンカルボン酸ナトリウム、L-ヒドロキシプロリン、塩化カルシウム、塩化マグネシウム);各種抽出物(例えば、バラ、オウバク、オウレン、シコン、シャクヤク、センブリ、バーチ、セージ、ビワ、ニンジン、アロエ、ゼニアオイ、アイリス、ブドウ、ヨクイニン、ヘチマ、ユリ、サフラン、センキョウ、ショウキョウ、オトギリソウ、オノニス、ニンニク、トウガラシ、チンピ、トウキ、海藻等);その他水溶性薬剤(例えば、トラネキサム酸)等の有効成分が挙げられ、これらの配合により本発明の化粧料に所望の効果を付加することができる。
 なお、必須成分である増粘剤及びトレハロースも、本発明に保湿効果をもたらし得る。
Other ingredients that can be added include, for example, humectants (eg, 2-methacryloyloxyethyl phosphorylcholine (MPC) copolymer, PEG / PPG dimethyl ether such as PEG / PPG-14 / 7 dimethyl ether), water-soluble collagen, hydrogen peroxide treatment Yeast hydrolysate, sodium dl-prolidonecarboxylate, L-hydroxyproline, calcium chloride, magnesium chloride); various extracts (eg, rose, apricot, auren, sicon, peonies, assembly, birch, sage, loquat, carrot , Aloe, mallow, iris, grape, yokuinin, loofah, lily, saffron, senkyo, ginger, hypericum, onionis, garlic, capsicum, chimpi, cypress, seaweed, etc.); other water-soluble drugs (eg, tranexamic acid), etc. The active ingredient and the like, can be added the desired effect in the cosmetic of the present invention these formulations.
In addition, the thickener and trehalose which are essential components can also provide a moisturizing effect in the present invention.
 本発明に係るタブレット型化粧料は、上記配合成分を水や低級アルコール等の揮発性液状媒体に溶解又は分散し、凍結後減圧して昇華させることで後に残る乾燥物として得ることができる。
 本発明に係るタブレット型化粧料の製造において、水等の媒体に溶解された上記賦形剤成分は、媒体中で3次元の網目状構造を形成する。そのような状態から、媒体のみを除去しようとすると、乾燥によって網目構造が収縮し、歪んだり崩れたりすることから、通常は該構造を維持することは難しい。しかし、本発明においては、前記賦形剤とともに配合されるトレハロースが媒体揮発後も媒体に代わって網目状構造を支持するため、賦形剤による構造がほぼ維持されると考えられる。
The tablet-type cosmetics according to the present invention can be obtained as a dry product that remains after dissolving or dispersing the above-described blended components in a volatile liquid medium such as water or lower alcohol, and sublimating by freezing after freezing.
In the manufacture of the tablet-type cosmetic according to the present invention, the excipient component dissolved in a medium such as water forms a three-dimensional network structure in the medium. If only the medium is removed from such a state, the network structure shrinks due to drying, and is distorted or collapsed. Therefore, it is usually difficult to maintain the structure. However, in the present invention, trehalose blended with the excipient supports the network structure instead of the medium even after volatilization of the medium, so that it is considered that the structure by the excipient is almost maintained.
 また、賦形剤の3次元網目状構造が維持された乾燥物は、該構造から媒体部分が抜けた多孔状態であり、再溶解時に水を加えると、各孔より網目状構造内部へ水が浸透し、タブレット製剤全体の溶解が進む。その際、上記構造物を含む構成成分の密度が高いほど水は内部へ浸透し難くなり、製剤は溶解し難くなる。一方、構成成分の密度が低すぎると、製剤そのものが脆く、崩れやすくなり、また、保存時に湿気を吸い易くなる。
 そのため、瞬時に水が浸透し、製剤が崩壊するような溶解性をもつ一方で、保存時の吸湿性は極めて低い製剤とするには、さらに、構成成分の嵩密度を一定の範囲に設定する必要がある。
In addition, the dried product in which the three-dimensional network structure of the excipient is maintained is in a porous state in which the medium portion has been removed from the structure. When water is added during re-dissolution, water is introduced into the network structure from each hole. Penetration and dissolution of the entire tablet formulation proceeds. At that time, the higher the density of the constituents including the structure, the more difficult the water penetrates into the interior, and the formulation becomes less soluble. On the other hand, if the density of the constituent components is too low, the preparation itself is fragile and easily collapses, and it is easy to absorb moisture during storage.
For this reason, in order to make a formulation that has extremely low hygroscopicity during storage, while having a solubility that allows water to permeate and disintegrate instantaneously, the bulk density of the constituents is further set within a certain range. There is a need.
 そのため、本発明に係るタブレット型化粧料においては、上記構成成分を含み、且つ、その嵩比重が0.1~0.5g/ml、好ましくは0.15~0.3g/mlとすることを要する。
 嵩比重が0.1g/mlに満たないと保存時の吸湿性が高くなり、0.5g/mlを超えると水への溶解性が低下する傾向がある。一方で、嵩比重が前記範囲内にあると、媒体が抜けた孔が適度な多さとなり、且つ増粘剤の網目構造も適度に広がった状態で固定され、水を添加して再溶解させた際に、極めて良好な溶解性となる。
Therefore, the tablet cosmetic according to the present invention contains the above-described constituents and has a bulk specific gravity of 0.1 to 0.5 g / ml, preferably 0.15 to 0.3 g / ml. Cost.
If the bulk specific gravity is less than 0.1 g / ml, the hygroscopicity during storage increases, and if it exceeds 0.5 g / ml, the solubility in water tends to decrease. On the other hand, if the bulk specific gravity is within the above range, the number of holes through which the medium has escaped is moderately large, and the network structure of the thickener is also fixed in a moderately widened state. In this case, the solubility is extremely good.
 嵩比重の測定方法としては、凍結乾燥後のタブレットの重量(g)÷凍結乾燥型の容積(ml)にて算出する。 As a method for measuring the bulk specific gravity, the tablet weight after freeze-drying (g) ÷ freeze-drying type volume (ml) is calculated.
 本発明に係るタブレット型化粧料は、例えば、構成成分を水や低級アルコール等の揮発性液状媒体に溶解又は分散した溶液をタブレット型に充填後、これを凍結乾燥させ、必要に応じて前記型から取り出すことにより製造することができる。
 本発明は、上記嵩比重を満たすように製剤の体積と構成成分及び媒体の量を設定することによって、あらゆる大きさ及び形状に成型され得る。
 ただし、極端に細い形状や複雑すぎる形状は成形性などで問題があるため好ましくない。
 また、本発明は製剤の吸湿性が低く、また、離型性が高く容器から剥離し易いため、容器に充填したまま使用分毎に包装する形態(例えば、ブリスターパック)に限らず、容器(型)から外した製剤のみを任意の形態で包装することも可能である。
The tablet-type cosmetic according to the present invention is, for example, filled in a tablet mold with a solution in which constituent components are dissolved or dispersed in a volatile liquid medium such as water or lower alcohol, and then freeze-dried. It can manufacture by taking out from.
The present invention can be molded into any size and shape by setting the volume of the preparation, the components and the amount of the medium so as to satisfy the above-mentioned bulk specific gravity.
However, an extremely thin shape or an excessively complicated shape is not preferable because there is a problem in moldability.
Further, the present invention has a low hygroscopic property of the preparation, and has a high releasability and is easily peeled from the container. Therefore, the present invention is not limited to a form (for example, blister pack) packaged for each used portion while being filled in the container. Only the preparation removed from the mold) can be packaged in any form.
 本発明に係るタブレット型化粧料は、通常、適量の水を加えて製剤を再溶解させ、その溶液を皮膚等に塗布することにより使用することができる。水の添加量は、製剤が完全に溶解する程度を下限に、塗布し易い粘度となるように調製すればよいが、多すぎると、成分濃度が低くすぎて十分な効果が得られないことがあり、少なすぎると塗布時にべたつくことがある。したがって、特に限定はされないが、製剤の体積の1~10倍程度で添加量を調整することが好ましい。
 また、製剤へ水を加える場所は、掌上や適用部位であっても、適当な容器内等であってもよいが、本発明の使用方法として、1回使用分の製剤を掌上に載せ、製剤に水を加えた後、掌上の溶解液をそのまま適用部位へ手で塗布することが好ましい。
 なお、製剤の再溶解が可能であれば、水に代えて化粧水等を用いてもよい。
The tablet-type cosmetics according to the present invention can usually be used by adding an appropriate amount of water to redissolve the preparation and applying the solution to the skin or the like. The amount of water to be added should be adjusted so that the viscosity is easy to apply, with the lower limit of the complete dissolution of the preparation, but if it is too much, the component concentration is too low to obtain a sufficient effect. Yes, if it is too little, it may become sticky at the time of application. Therefore, although not particularly limited, it is preferable to adjust the addition amount to about 1 to 10 times the volume of the preparation.
The place where water is added to the preparation may be on the palm, on the application site, or in a suitable container. However, as a method of using the present invention, the preparation for one-time use is placed on the palm. After adding water, it is preferable to apply the solution on the palm as it is to the application site by hand.
Note that lotion or the like may be used instead of water as long as the formulation can be redissolved.
 本発明に係るタブレット型化粧料は、配合する成分により、化粧水、美容液、パック、クレンジング、洗顔フォーム、ハンドクリーム、シャンプー、リンス、ヘアートリートメント、日焼け止め等、任意の製品形態とすることができ、特に、保湿用の化粧水や美容液としての使用が好適である。 The tablet-type cosmetic according to the present invention may be in any product form, such as lotion, cosmetic liquid, pack, cleansing, facial cleansing foam, hand cream, shampoo, rinse, hair treatment, sunscreen, etc., depending on the ingredients to be blended. In particular, it is suitable for use as a moisturizing lotion or cosmetic liquid.
 以下、実施例を挙げて本発明について詳述するが、本発明はこれらにより何ら限定されるものではない。配合量は特記しない限り、その成分が配合される系に対する質量%で示す。
 まず、以下の試験で用いた評価方法及び評価基準について説明する。
EXAMPLES Hereinafter, although an Example is given and this invention is explained in full detail, this invention is not limited at all by these. Unless otherwise specified, the blending amount is expressed in mass% with respect to the system in which the component is blended.
First, the evaluation method and evaluation criteria used in the following tests will be described.
<溶解性>
 各試験例組成物(約100mg)を手のひらに載せ、500μl水を滴下してから、指でなじませ製剤が完全に溶解するまでに要した時間について、下記の基準で評価した。
  A:製剤は瞬時に完全に溶解した。
  B:製剤はやや時間を要するが完全に溶解した。
  C:製剤はやや溶けにくく一部溶け残りが生じた。
  D:製剤は溶けにくく溶け残りが生じた。
  E:製剤は溶けなかった。
<Solubility>
Each test example composition (about 100 mg) was placed on the palm, 500 μl of water was dropped, and the time required for the formulation to dissolve completely was evaluated according to the following criteria.
A: The preparation completely dissolved instantly.
B: The preparation required a little time but dissolved completely.
C: The preparation was slightly difficult to dissolve, and a part of the undissolved part was generated.
D: The preparation was difficult to dissolve and a residue was left undissolved.
E: The preparation did not dissolve.
<使用性>
 各試験例組成物(約100mg)を掌上に載せ、500μlの水を加えて溶解させ、肌に塗布した際の使用感触(しっとりさ、べたつきのなさ、肌のなめらかさ)について、10名の専門パネルにより下記の基準で評価した。
  A:10名中6名以上が、使用感触が良いと回答した。
  B:10名中3名以上6名未満が、使用感触が良いと回答した。
  C:10名中3名未満が、使用感触が良いと回答した。
<Usability>
Each test example composition (about 100 mg) is placed on the palm, added with 500 μl of water, dissolved and applied to the skin (moistness, non-stickiness, smoothness of the skin) by 10 experts The panel evaluated as follows.
A: 6 or more out of 10 responded that the feeling of use was good.
B: 3 or more and less than 6 out of 10 responded that the feeling of use was good.
C: Less than 3 out of 10 responded that the feeling of use was good.
<離型性>
 各試験例組成物の製造方法における乾燥工程後、乾燥物を容器から取り出す際の離れ易さについて、下記の基準で評価した。
  A:製剤が容器から非常に容易に離れた。
  B:製剤が容器から容易に離れた。
  C:製剤が容器からやや離れ難かった。
  D:製剤が容器から非常に離れ難かった。
<Releasability>
After the drying step in the production method of each test example composition, the ease with which the dried product was taken out from the container was evaluated according to the following criteria.
A: The formulation was very easily removed from the container.
B: The formulation was easily removed from the container.
C: The preparation was slightly difficult to leave from the container.
D: The preparation was very difficult to leave from the container.
<成形性>
 各試験例組成物の製造方法における乾燥工程後の成形性について、下記の基準で評価した。
  A:製剤が容器から成形型どおりに成形された。
  B:製剤が容器からほぼ成形型どおりに成形された。
  C:製剤が容器から小さなクラックが生じたが成形された。
  D:製剤が容器から小さくなるなど成形型どおりに成形されなかった。
  E:製剤が容器から大きなクラックが生じた、またはもろく割れが生じた。
<Moldability>
The moldability after the drying step in the production method of each test example composition was evaluated according to the following criteria.
A: The preparation was molded from the container according to the mold.
B: The preparation was molded from the container almost according to the mold.
C: The preparation was molded with small cracks from the container.
D: The product was not molded according to the mold, for example, the formulation became smaller from the container.
E: The preparation had a large crack from the container or a brittle crack.
 下記各表に記載する処方の試験例組成物は、下記製造方法に従って調製した。
<製造方法>
 各種配合成分を水や低級アルコール等の揮発性液状媒体に溶解又は分散し、成形型に流し込み、凍結後減圧して昇華させることで後に残る乾燥物としてタブレット型凍結乾燥化粧料を得た。
The test example compositions of the formulations described in the following tables were prepared according to the following production methods.
<Manufacturing method>
Various compounding ingredients were dissolved or dispersed in a volatile liquid medium such as water or lower alcohol, poured into a mold, sublimed by freezing after freezing, and a tablet-type freeze-dried cosmetic was obtained as a dry product remaining later.
 まず、本発明者は、賦形剤として用いる糖についてのタブレット化粧料の成形性の検討を行った。
 以下の表1に掲げる試験例の処方は以下の通りである。
First, this inventor examined the moldability of the tablet cosmetics about the saccharide | sugar used as an excipient | filler.
The prescriptions for the test examples listed in Table 1 below are as follows.
イオン交換水       残量
各種糖          表1に示す配合量
合計           100質量%
Ion-exchanged water Remaining sugars Total amount shown in Table 1 100%
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
 このことから、賦形剤の基本骨格としては、糖の中でも、トレハロースを用いることが成形性の点で、優れていることがわかった。
 したがって、本発明者は、以下において、トレハロースの配合量の検討をした。
From this, it was found that, as the basic skeleton of the excipient, trehalose is excellent in terms of moldability among sugars.
Therefore, the inventor examined the blending amount of trehalose in the following.
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
 試験例2-1~2-6から分かるように、トレハロースの配合量が、20質量%を超えると、突沸してしまうため、成形性の観点から好ましくない。また、再溶解性としては、トレハロースの配合量が20質量%を超えると、溶け残りがあるため、好ましくない。 As can be seen from Test Examples 2-1 to 2-6, if the amount of trehalose exceeds 20% by mass, bumping occurs, which is not preferable from the viewpoint of moldability. Moreover, as re-solubility, when the compounding quantity of trehalose exceeds 20 mass%, since there exists undissolved, it is unpreferable.
 そこで、本発明者は、その他の成分として、(B)ポリエチレングリコールを加えることで、成型性と離型性を改善することができるか検討した。 Therefore, the present inventor examined whether or not moldability and releasability could be improved by adding (B) polyethylene glycol as another component.
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
 (*1)トレハロース;株式会社林原社製 (* 1) Trehalose; Hayashibara Co., Ltd.
 試験例3-1~3-2から分かるように、(B)ポリエチレングリコールを加えると、再溶解性を維持したまま、成形性および離型性に優れた賦形剤となることが分かった。 As can be seen from Test Examples 3-1 and 3-2, it was found that when (B) polyethylene glycol was added, an excipient excellent in moldability and releasability was obtained while maintaining re-solubility.
 本発明者は、さらに、タブレット化粧料としての使用性について検討した。 The present inventor further examined the usability as a tablet cosmetic.
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
 (*3)バイオヒアロ 12;資生堂社製
 (*4)グリロイド6C;大日本製薬社製
 (*5)Lipdure-PMB(Ph10);日油社製
(* 3) Bio Hiaro 12; manufactured by Shiseido Co., Ltd. (* 4) Glyroid 6C; manufactured by Dainippon Pharmaceutical Co., Ltd. (* 5) Lipdure-PMB (Ph10); manufactured by NOF Corporation
Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005
 表4および表5より、使用性を向上するためには、(B)ポリエチレングリコールを配合しつつ、さらに、保湿剤と増粘剤を加えることで、成形性、離型性、再溶解性を維持したまま、使用性を向上できることが分かった。 From Table 4 and Table 5, in order to improve the usability, (B) while blending polyethylene glycol, by further adding a moisturizing agent and a thickening agent, moldability, releasability, re-dissolvability It was found that the usability can be improved while maintaining.
 次に、配合する(B)ポリエチレングリコールの数平均分子量の検討を行った。 Next, the number average molecular weight of the blended (B) polyethylene glycol was examined.
Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006
 試験例6-1から6-7より、(B)ポリエチレングリコールは、数平均分子量が4000~20000であることが、成形性および使用性の点では好ましい。 From Test Examples 6-1 to 6-7, the polyethylene glycol (B) preferably has a number average molecular weight of 4,000 to 20,000 in terms of moldability and usability.
Figure JPOXMLDOC01-appb-T000007
*アルコールはエタノールを使用した。
Figure JPOXMLDOC01-appb-T000007
* Ethanol was used as alcohol.
Figure JPOXMLDOC01-appb-T000008
*アルコールはエタノールを使用した。
Figure JPOXMLDOC01-appb-T000008
* Ethanol was used as alcohol.
 試験例7-1~7-6は、再溶解性、使用性に優れ、さらに、高温安定性にも優れたタブレット化粧料であった。 Test Examples 7-1 to 7-6 were tablet cosmetics excellent in re-dissolvability and usability, and excellent in high-temperature stability.
 本発明のタブレット型凍結乾燥化粧料(洗浄剤)の処方例は以下である。 The formulation example of the tablet-type freeze-dried cosmetic (detergent) of the present invention is as follows.
Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009
 本発明のタブレット型凍結乾燥化粧料(ヘアートリートメント)の処方例は以下である。
The formulation example of the tablet-type freeze-dried cosmetic (hair treatment) of the present invention is as follows.
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000010
 本発明のタブレット型凍結乾燥化粧料(シャンプー)の処方例は以下である。 The formulation example of the tablet-type freeze-dried cosmetic (shampoo) of the present invention is as follows.
Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000011
  本発明のタブレット型凍結乾燥化粧料(皮膚塗布用化粧料)の処方例4~7は以下である。
Formulation examples 4 to 7 of the tablet-type freeze-dried cosmetic (cosmetic for skin application) of the present invention are as follows.
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000012
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000013
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000014
Figure JPOXMLDOC01-appb-T000015
Figure JPOXMLDOC01-appb-T000015

Claims (6)

  1.  (A)トレハロース 10~20質量%と、
     (B)数平均分子量2500~20000のポリエチレングリコール 0.5~3.0質量%と、
    を含み、且つ、嵩比重が0.1~0.5g/mlであることを特徴とするタブレット型凍結乾燥化粧料。
    (A) 10-20% by mass of trehalose,
    (B) 0.5 to 3.0% by mass of polyethylene glycol having a number average molecular weight of 2500 to 20000,
    And a tablet-type freeze-dried cosmetic characterized by having a bulk specific gravity of 0.1 to 0.5 g / ml.
  2.  請求項1に記載の化粧料において、(B)は数平均分子量15000~20000のポリエチレングリコールを含むことを特徴とするタブレット型凍結乾燥化粧料。 2. The tablet-type freeze-dried cosmetic according to claim 1, wherein (B) comprises polyethylene glycol having a number average molecular weight of 15000 to 20000.
  3.  請求項1または2に記載の化粧料において、(C)ヒアルロン酸及び(D)増粘剤を含むことを特徴とするタブレット型凍結乾燥化粧料。 3. The tablet-type freeze-dried cosmetic according to claim 1, wherein the cosmetic comprises (C) hyaluronic acid and (D) a thickener.
  4.  請求項1~3のいずれかに記載の化粧料において、(C)ヒアルロン酸の配合量が0.01~1質量%であることを特徴とするタブレット型凍結乾燥化粧料。 The tablet-type freeze-dried cosmetic according to any one of claims 1 to 3, wherein the blending amount of (C) hyaluronic acid is 0.01 to 1% by mass.
  5.  請求項4に記載の化粧料において、(D)増粘剤の配合量が0.01~0.5質量%であることを特徴とするタブレット型凍結乾燥化粧料。 5. The tablet-type freeze-dried cosmetic according to claim 4, wherein the blending amount of (D) thickener is 0.01 to 0.5% by mass.
  6.  請求項3~5のいずれかに記載の化粧料において、(D)増粘剤がキサンタンガム、タマリンドガム、アルギン酸ナトリウム、ジェランガム、寒天、ポリビニルアルコール、カルボキシビニルポリマー、クインスシードから選択されることを特徴とするタブレット型凍結乾燥化粧料。 The cosmetic according to any one of claims 3 to 5, wherein (D) the thickener is selected from xanthan gum, tamarind gum, sodium alginate, gellan gum, agar, polyvinyl alcohol, carboxyvinyl polymer, and quince seed. A tablet-type freeze-dried cosmetic.
PCT/JP2016/087423 2015-12-16 2016-12-15 Tablet-type freeze-dried cosmetic WO2017104759A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015-245470 2015-12-16
JP2015245470 2015-12-16

Publications (1)

Publication Number Publication Date
WO2017104759A1 true WO2017104759A1 (en) 2017-06-22

Family

ID=59056867

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/087423 WO2017104759A1 (en) 2015-12-16 2016-12-15 Tablet-type freeze-dried cosmetic

Country Status (3)

Country Link
JP (1) JP2017110001A (en)
TW (1) TW201726100A (en)
WO (1) WO2017104759A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102641043B1 (en) * 2017-01-06 2024-02-26 가부시키가이샤 미르본 Composition for hair and hair treatment method
JP2022126833A (en) * 2017-01-06 2022-08-30 株式会社ミルボン Hair composition and hair treatment method
JP6404405B1 (en) * 2017-06-14 2018-10-10 株式会社 資生堂 Tablet-type freeze-dried cosmetics
KR20200016878A (en) * 2017-06-19 2020-02-17 가부시키가이샤 시세이도 Tablet Freeze Dried Cosmetic
EP4201392A1 (en) 2021-12-21 2023-06-28 Universitat Internacional De Catalunya, Fundació Privada Solid personal care product and method to obtain such product

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61180800A (en) * 1985-02-06 1986-08-13 Kanebo Ltd Powdery silk fibroin peptide and production thereof
JPH0368507A (en) * 1989-08-07 1991-03-25 Shiseido Co Ltd Solid cosmetic composition
JPH08507064A (en) * 1993-02-23 1996-07-30 ジェネンテク・インコーポレイテッド Excipient stabilization of polypeptides treated with organic solvents
JPH08245418A (en) * 1995-03-09 1996-09-24 Behringwerke Ag Stable transglutaminase pharmaceutical preparation and its preparation
JP2001327280A (en) * 2000-05-23 2001-11-27 Lion Corp Freeze-preserving liquid for bacteria
JP2006509525A (en) * 2002-12-13 2006-03-23 ザイモジェネティクス, インコーポレイテッド Production of IL-21 in prokaryotic hosts
JP2006182750A (en) * 2004-12-27 2006-07-13 Bio Meito:Kk Freeze-dried cosmetic and method for producing the same
JP2012017304A (en) * 2010-07-09 2012-01-26 Fancl Corp L-ascorbic acid-2-phosphate-6-fatty acid lyophilized formulation and cosmetic
JP2014514275A (en) * 2011-03-10 2014-06-19 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム Protein nanoparticle dispersion system
JP2014148555A (en) * 1995-07-27 2014-08-21 Genentech Inc Protein formulation
JP2015061871A (en) * 2009-09-03 2015-04-02 株式会社林原 POWDER CONTAINING ANHYDROUS CRYSTAL OF 2-O-α-D-GLUCOSYL-L-ASCORBIC ACID, METHOD FOR PRODUCING THE SAME, AND USE THEREOF
JP2015224219A (en) * 2014-05-28 2015-12-14 大日本住友製薬株式会社 Lyophilized products

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61180800A (en) * 1985-02-06 1986-08-13 Kanebo Ltd Powdery silk fibroin peptide and production thereof
JPH0368507A (en) * 1989-08-07 1991-03-25 Shiseido Co Ltd Solid cosmetic composition
JPH08507064A (en) * 1993-02-23 1996-07-30 ジェネンテク・インコーポレイテッド Excipient stabilization of polypeptides treated with organic solvents
JPH08245418A (en) * 1995-03-09 1996-09-24 Behringwerke Ag Stable transglutaminase pharmaceutical preparation and its preparation
JP2014148555A (en) * 1995-07-27 2014-08-21 Genentech Inc Protein formulation
JP2001327280A (en) * 2000-05-23 2001-11-27 Lion Corp Freeze-preserving liquid for bacteria
JP2006509525A (en) * 2002-12-13 2006-03-23 ザイモジェネティクス, インコーポレイテッド Production of IL-21 in prokaryotic hosts
JP2006182750A (en) * 2004-12-27 2006-07-13 Bio Meito:Kk Freeze-dried cosmetic and method for producing the same
JP2015061871A (en) * 2009-09-03 2015-04-02 株式会社林原 POWDER CONTAINING ANHYDROUS CRYSTAL OF 2-O-α-D-GLUCOSYL-L-ASCORBIC ACID, METHOD FOR PRODUCING THE SAME, AND USE THEREOF
JP2012017304A (en) * 2010-07-09 2012-01-26 Fancl Corp L-ascorbic acid-2-phosphate-6-fatty acid lyophilized formulation and cosmetic
JP2014514275A (en) * 2011-03-10 2014-06-19 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム Protein nanoparticle dispersion system
JP2015224219A (en) * 2014-05-28 2015-12-14 大日本住友製薬株式会社 Lyophilized products

Also Published As

Publication number Publication date
TW201726100A (en) 2017-08-01
JP2017110001A (en) 2017-06-22

Similar Documents

Publication Publication Date Title
WO2017104759A1 (en) Tablet-type freeze-dried cosmetic
JP6113944B2 (en) Freeze-dried molded product, production method thereof, and use thereof
US20220087908A1 (en) Manufacture of freeze-dried cosmetic
TW201238608A (en) Fluid compositions
JP6519930B2 (en) Water soluble hyaluronic acid gel and method for producing the same
JP6125859B2 (en) Composition for external use
KR102439781B1 (en) Oil-in-water cosmetic composition having low-viscosity with stabilized high content oil
KR20180006068A (en) Disposable lightweight freeze-dried cosmetics
EP3967372A1 (en) Gel-type external composition for skin
JP2017043588A (en) Kit for skin external preparation
JP6404405B1 (en) Tablet-type freeze-dried cosmetics
JP4495748B2 (en) L-ascorbic acid-2-phosphate-6-fatty acid lyophilized preparation and cosmetics
JP2006249030A (en) Sheet-like cosmetic, cosmetic composition and method for using cosmetic
TWI787186B (en) Tablet type freeze-dried cosmetic
JP5434023B2 (en) Oral composition
JP6181686B2 (en) Effervescent skin preparation
EP2554158A1 (en) Solid or powdery hair styling composition
JP7118931B2 (en) oral composition
JP6359302B2 (en) Cosmetic gel and cosmetics containing the same
KR102653555B1 (en) Composition with stabilized active ingredient
WO2023182488A1 (en) Emulsion composition
TWI282740B (en) Liquid cosmetics
JP2018118957A (en) Gelatinous composition
JP2008239508A (en) alpha-LIPOIC ACID-CONTAINING TRANSPARENT AQUEOUS COSMETIC
JP2006169212A (en) Gel-form composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16875736

Country of ref document: EP

Kind code of ref document: A1

WA Withdrawal of international application
NENP Non-entry into the national phase

Ref country code: DE